{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:32:20Z","timestamp":1769603540239,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13052-018-0450-8","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T07:59:02Z","timestamp":1516003142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early neonatal Glutaric aciduria type I hidden by perinatal asphyxia: a case report"],"prefix":"10.1186","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7441-9248","authenticated-orcid":false,"given":"Giacomo","family":"Biasucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Natacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"450_CR1","volume-title":"Neurology of the newborn","author":"JJ Volpe","year":"2008","unstructured":"Volpe JJ. Neonatal seizures. In: Volpe JJ, editor. Neurology of the newborn. 5th ed. Philadelphia: WB Saunders; 2008. Chapter 5.","edition":"5"},{"key":"450_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10545-016-9999-9","volume":"40","author":"N Boy","year":"2017","unstructured":"Boy N, M\u00fchlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, Dixon M, et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40:75\u2013101.","journal-title":"J Inherit Metab Dis"},{"key":"450_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0006-2944(75)90091-5","volume":"12","author":"SI Goodman","year":"1975","unstructured":"Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC. Glutaric aciduria: a new inborn error of amino acid metabolism. Biochem Med. 1975;12:12\u201321.","journal-title":"Biochem Med"},{"key":"450_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0009-8981(83)90155-9","volume":"129","author":"E Christensen","year":"1983","unstructured":"Christensen E. Improved assay of glutaryl-CoA dehydrogenase in cultured cells and liver: application to glutaric aciduria type I. Clin Chim Acta. 1983;129:91\u20137.","journal-title":"Clin Chim Acta"},{"key":"450_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/jmg.37.3.177","volume":"37","author":"J Zschocke","year":"2000","unstructured":"Zschocke J, Quak E, Guldberg P, Hoffmann GF. Mutation analysis in glutaric aciduria type I. J Med Genet. 2000;37:177\u201381.","journal-title":"J Med Genet"},{"key":"450_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ymgme.2012.03.021","volume":"107","author":"S K\u00f6lker","year":"2012","unstructured":"K\u00f6lker S, Boy SP, Heringer J, et al. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - a decade of experience. Mol Genet Metab. 2012;107:72\u201380.","journal-title":"Mol Genet Metab"},{"key":"450_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10545-012-9517-7","volume":"36","author":"N Boy","year":"2013","unstructured":"Boy N, Haege G, Heringer J, et al. Low lysine diet in glutaric aciduria type I-effect on anthropometric and biochemical follow up parameters. J Inherit Metab Dis. 2013;36:525\u201333.","journal-title":"J Inherit Metab Dis"},{"key":"450_CR8","first-page":"162","volume":"29","author":"RA Chalmers","year":"2006","unstructured":"Chalmers RA, Bain MD, Zschocke J. Riboflavin-responsive glutaryl-CoA dehydrogenase deficiency. Mol GenetMetab. 2006;29:162\u201372.","journal-title":"Mol GenetMetab"},{"key":"450_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10545-011-9289-5","volume":"34","author":"S K\u00f6lker","year":"2011","unstructured":"K\u00f6lker S, Christensen E, Leonard JV. Diagnosis and management of glutaric aciduria type I\u2013revised recommendations. J InheritMetab Dis. 2011;34:677\u201394.","journal-title":"J InheritMetab Dis"},{"key":"450_CR10","first-page":"CD006659","volume":"2","author":"M Nasser","year":"2009","unstructured":"Nasser M, Javaheri H, Fedorowicz Z, Noorani Z. Carnitine supplementation for inborn errors of metabolism. Cochrane Database Syst Rev. 2009;2:CD006659.","journal-title":"Cochrane Database Syst Rev"},{"key":"450_CR11","first-page":"489","volume":"38","author":"NK Desai","year":"2003","unstructured":"Desai NK, Runge VM, Crisp DE, Crisp MB, Naul LG. Magnetic resonance imaging of the brain in glutaric aciduria type I. Investig Radiol. 2003;38:489\u201396.","journal-title":"Investig Radiol"},{"key":"450_CR12","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s00247-015-3395-8","volume":"45","author":"SA Mohammad","year":"2015","unstructured":"Mohammad SA, Abdelkhalek HS, Ahmed KA, et al. Glutaric aciduria type 1: neuroimaging features with clinical correlation. Pediatr Radiol. 2015;45:1696\u2013705.","journal-title":"Pediatr Radiol"},{"key":"450_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1023\/B:BOLI.0000045776.50573.52","volume":"27","author":"AP Burlina","year":"2004","unstructured":"Burlina AP, Zara G, Hoffmann GF, Zschocke J, Burlina AB. Management of movement disorders in glutaryl-CoA dehydrogenase deficiency : anticholinergic drugs and botulinum toxin as additional therapeutic options. J Inherit Metab Dis. 2004;27:911\u20135.","journal-title":"J Inherit Metab Dis"},{"key":"450_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2007-973761","volume":"27","author":"GF Hoffmann","year":"1996","unstructured":"Hoffmann GF, Athanassopoulos S, Burlina AB, et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 1996;27:115\u201323.","journal-title":"Neuropediatrics"},{"key":"450_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","volume":"38","author":"S K\u00f6lker","year":"2015","unstructured":"K\u00f6lker S, Valayannopoulos V, Burlina AB, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis. 2015b;38:1059\u201374.","journal-title":"J Inherit Metab Dis"},{"key":"450_CR16","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/brain\/awp112","volume":"132","author":"I Harting","year":"2009","unstructured":"Harting I, Neumaier-Probst E, Seitz A, et al. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain. 2009;132:1764\u201382.","journal-title":"Brain"},{"key":"450_CR17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1203\/01.pdr.0000219387.79887.86","volume":"59","author":"S K\u00f6lker","year":"2006","unstructured":"K\u00f6lker S, Garbade S, Greenberg CR, et al. Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res. 2006;59:840\u20137.","journal-title":"Pediatr Res"},{"key":"450_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","volume":"38","author":"S K\u00f6lker","year":"2015","unstructured":"K\u00f6lker S, Cazorla AG, Valayannopoulos V, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015a;38:1041\u201357.","journal-title":"J Inherit Metab Dis"},{"key":"450_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13023-014-0197-2","volume":"9","author":"EL Leach","year":"2014","unstructured":"Leach EL, Shevell M, Bowden K, Stockler-Ipsiroglu S, van Karnebeek Clara DM. Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review. Orphanet Journal of Rare Diseases. 2014;9:197.","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"450_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1067\/mpd.2000.108954","volume":"137","author":"KB Bjugstad","year":"2000","unstructured":"Bjugstad KB, Goodman SI, Freed CR. Age at symptom onset predicts severity of motor impairment and clinical onset of glutaric aciduria type I. J Pediatr. 2000;137:681\u20136.","journal-title":"J Pediatr"},{"key":"450_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1750-1172-8-167","volume":"8","author":"J Pfeil","year":"2013","unstructured":"Pfeil J, Listl S, Hoffmann GF, et al. Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis. 2013;8:167.","journal-title":"Orphanet J Rare Dis"},{"key":"450_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ymgme.2012.05.024","volume":"106","author":"K Viau","year":"2012","unstructured":"Viau K, Ernst SL, Vanzo RJ, et al. Glutaric acidemia type 1:outcomes before and after expanded newborn screening. Mol Genet Metab. 2012;106:430\u20138.","journal-title":"Mol Genet Metab"},{"key":"450_CR23","first-page":"593","volume":"64","author":"B Afroze","year":"2014","unstructured":"Afroze B, Yunus ZM. Glutaric aciduria type 1\u2013importance of early diagnosis and treatment. J Pak Med Assoc. 2014;64:593\u20135.","journal-title":"J Pak Med Assoc"},{"key":"450_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11011-012-9349-z","volume":"28","author":"CS Lee","year":"2013","unstructured":"Lee CS, Chien YH, Peng SF, et al. Promising outcomes in glutaric aciduria type I patients detected by newborn screening. Metab Brain Dis. 2013;28:61\u20137.","journal-title":"Metab Brain Dis"},{"key":"450_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1203\/PDR.0b013e318137a124","volume":"62","author":"S K\u00f6lker","year":"2007","unstructured":"K\u00f6lker S, Garbade SF, Boy N, et al. Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by neonatal screening in Germany. Pediatr Res. 2007;62:353\u201362.","journal-title":"Pediatr Res"},{"key":"450_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejpn.2013.01.003","volume":"17","author":"ML Couce","year":"2013","unstructured":"Couce ML, L\u00f3pez-Su\u00e1rez O, B\u00f3veda MD, et al. A Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol. 2013;17:383\u20139.","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T19:34:34Z","timestamp":1547494474000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-018-0450-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1186\/s13052-018-0450-8","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"assertion":[{"value":"23 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. No ethical approval is required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors agree to submit the manuscript to the IJP for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"8"}}